This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Merck & Co., Inc.
Drug Names(s): MK-0941
Description: MK-0941 is a novel glucokinase activator (GKA). Preclinical studies with MK-0941 showed robust glucose-lowering effects both acutely and chronically in association with hypoglycemia in fasted and fed non-diabetic animals.
Additional information available to subscribers only: